Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001998653-24-000007
Filing Date
2024-12-30
Accepted
2024-12-30 17:21:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4827
  Complete submission text file 0001998653-24-000007.txt   6626
Mailing Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484
Business Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484 203-221-7381
INTENSITY THERAPEUTICS, INC. (Subject) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94388 | Film No.: 241590623
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 401 PENNSYLVANIA PKWY SUITE 100 INDIANAPOLIS IN 46280
Business Address 401 PENNSYLVANIA PKWY SUITE 100 INDIANAPOLIS IN 46280 3177190157
SAPIENT CAPITAL LLC (Filed by) CIK: 0001998653 (see all company filings)

EIN.: 922406928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G